scleroderma is a progressive autoimmune disease that results in the overproduction of collagen, which hardens the skin. although collagen typically has a softening effect, when it is allowed to accumulate it makes the skin thicken and scar. according to scleroderma canada , the rare condition can also produce vascular lesions in small blood vessels that contribute to this thickening while also threatening some of the body’s major organs. there are two main forms of the disease: localized scleroderma (which primarily affects the skin and has a better long-term prognosis) and systemic scleroderma (which affects the skin, underlying tissues and major organs and involves more potential complications). there is no cure for the chronic disease but there are treatments to slow its progression and improve quality of life for patients.
for many patients, the first sign of scleroderma is a temporary decrease in the size of the blood vessels in the fingers and toes known as raynaud’s phenomenon. according to the scleroderma association of b.c. , this symptom, which is triggered by cold weather or emotional stress, can result in bluish skin, a whitening of the toes or fingers and numbness. this phenomenon is present in 95 per cent of people with scleroderma and can appear up to 10 years before other symptoms, making it a key clue in diagnosing the disease. while raynaud’s phenomenon is most common in the hands and feet, it can also affect the nose, tongue and ears and may be related to digital ulcers (collagen-induced sores that form on the fingertips).
advertisement
the five symptoms most commonly reported by systemic scleroderma patients, according to a study of 464 patients , are fatigue, raynaud’s phenomenon, hand stiffness, joint pain and difficulty sleeping.
advertisement
there is no currently no way to prevent the overproduction of collagen, according to the mayo clinic , so treatment typically involves a combination of drugs (to manage symptoms) and therapy (to improve strength and mobility). medications are often prescribed to:
scleroderma is five-to-six times more common in women than men and affects around 2.7 million people around the world, or one in 100 people. both main forms of the disease are associated with a slight decrease in life expectancy, with the systemic version usually leading to less favourable outcomes. more than 80 per cent of patients are women between the ages of 30 and 50 .
advertisement
scleroderma canada is a great place to learn more about the disease, including updates on the latest news and research. the site also features links to local scleroderma societies that may offer patient support in your area.
dave yasvinski is a writer with healthing.ca